Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Trading exchanges
Trading exchanges
NYSE
Products 11 to 20 of 23
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
BIO-SA De-icing solutions
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
North America
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:26 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Lubricant Additives and Base Stock
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
Canada
+
France
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:32 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
BioDirect Technology: RNAi pest control solution
by
Monsanto
Biotech components:
Enzyme
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
MON
(NYSE)
Value chain stage:
Finished Product
BioIsoprene
by
DuPont
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Cottonase Pectate Lyase
by
DuPont
+
Genencor
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
Netherlands
+
USA
+
Argentina
+
China
+
India
+
Pakistan
+
Singapore
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Danisco Xylanase
by
DuPont
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Phyzyme XP Phytase
by
DuPont
+
Danisco
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
+
Denmark
Country of distribution:
UK
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
RNA-based Biocontrols
by
Syngenta
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 11:25 (6 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
SYT
(NYSE)
Value chain stage:
Input
Sorona
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
North America
+
China
+
South Korea
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Succinic Acid
by
Myriant
+
Royal DSM
+
BioAmber, Inc.
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:37 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Health
+
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
+
Chemical
+
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
1
2
3
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
